NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) today announced the addition of seven leading academic medical and research centers to its national NORD® Rare Disease Centers of Excellence Network, expanding collaboration to improve care and accelerate research for the more than 30 million Americans living with rare conditions. With...

PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce a strategic collaboration with the Gorlin Syndrome Alliance (GSA) to advance compassionate access to SKINJECT™, the Company’s investigational...

By Raffaele Pereno – PhD, MBA BASEL, Switzerland – Reporting from the Festival of Biologics 2025, CheckOrphan attended a thought-provoking keynote panel featuring Dr. Marco Traub, Founder of the Trans European Stem Cell Therapy Society (TESCT), and Dr. Pedro Cruz, Chief Technical Operations Officer at iBET – Instituto de Biologia...